Principal Healthcare Innovators ETF Rating → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free BTEC Stock Alerts $35.65 -0.52 (-1.44%) (As of 05/10/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatingsShort InterestSocial MediaStock AnalysisChartHeadlinesHoldingsOwnershipRatingsShort InterestSocial Media Principal Healthcare Innovators ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BTEC Aggregate RatingModerate Buy2.70Holdings in BTEC have an aggregate rating of Moderate Buy based on 520 analyst ratings issued in the past year covering 50 companies (60.5% of the portfolio).BTEC Aggregate Price Target$48.6636.47% UpsideHigh Prediction$67.46Average Prediction$48.66Low Prediction$32.42Holdings in BTEC have an aggregate price target of $48.66 and a range of $32.42 to $67.46 covering 50 companies (60.5% of the portfolio).BTEC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy16 Buy rating(s)Moderate Buy26 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Principal Healthcare Innovators ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 BTEC Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.70%MRNAModerna$117.31-4.4%3 of 5 stars2.25$126.89 8.2%16Analyst ForecastInsider Selling3.16%ALNYAlnylam Pharmaceuticals$150.47-0.6%4 of 5 stars2.59$216.19 43.7%17Analyst ForecastShort Interest ↑Analyst Revision2.84%ILMNIllumina$110.53-0.7%5 of 5 stars2.30$164.65 49.0%20Analyst ForecastShort Interest ↓2.58%SRPTSarepta Therapeutics$131.82-0.4%4 of 5 stars2.79$160.60 21.8%142.39%NTRANatera$105.29+10.2%1 of 5 stars3.00$87.86 -16.6%15Earnings ReportAnalyst DowngradeInsider SellingNews CoverageGap UpHigh Trading Volume2.31%EXASExact Sciences$53.51-1.2%5 of 5 stars2.92$95.40 78.3%13Analyst ForecastShort Interest ↓Analyst RevisionNews CoverageHigh Trading Volume2.15%CTLTCatalent$55.81-0.3%3 of 5 stars2.15$52.46 -6.0%13Earnings ReportShort Interest ↓News Coverage1.92%ROIVRoivant Sciences$11.13-1.1%3 of 5 stars2.90$16.90 51.8%10Positive News1.75%VKTXViking Therapeutics$73.64-8.2%4 of 5 stars3.00$112.25 52.4%101.64%CERECerevel Therapeutics$42.19-0.3%0 of 5 stars2.11$42.67 1.1%9Short Interest ↓1.58%INSPInspire Medical Systems$167.83-3.8%5 of 5 stars2.69$256.53 52.9%16Earnings ReportAnalyst DowngradeAnalyst RevisionNews Coverage1.48%PCVXVaxcyte$65.19-0.6%1 of 5 stars3.00$78.50 20.4%4Earnings ReportAnalyst ForecastNews Coverage1.45%ITCIIntra-Cellular Therapies$64.96-0.9%5 of 5 stars2.90$90.17 38.8%10Earnings ReportAnalyst ForecastAnalyst Revision1.41%ELANElanco Animal Health$17.00-1.2%3 of 5 stars2.57$17.29 1.7%7Earnings ReportAnalyst ForecastShort Interest ↓Analyst RevisionNews Coverage1.41%CYTKCytokinetics$62.10-3.0%4 of 5 stars2.87$81.60 31.4%15Earnings ReportAnalyst ForecastInsider SellingNews Coverage1.40%BPMCBlueprint Medicines$106.70-1.5%1 of 5 stars2.50$100.31 -6.0%16Short Interest ↑Analyst Revision1.38%RVMDRevolution Medicines$37.25-0.5%4 of 5 stars3.10$41.60 11.7%10Earnings ReportAnalyst ForecastNews Coverage1.34%IONSIonis Pharmaceuticals$39.08-1.0%4 of 5 stars2.71$59.54 52.4%14Earnings ReportAnalyst ForecastInsider SellingShort Interest ↓1.31%IBRXImmunityBio$8.12+0.7%0 of 5 stars2.00$6.00 -26.1%1Gap Down1.22%APLSApellis Pharmaceuticals$41.99-1.2%4 of 5 stars2.87$76.67 82.6%15Earnings ReportAnalyst ForecastInsider SellingShort Interest ↑Analyst RevisionNews Coverage1.11%GKOSGlaukos$110.45+2.6%4 of 5 stars2.82$108.64 -1.6%11Short Interest ↑1.09%BBIOBridgeBio Pharma$29.10+1.3%4 of 5 stars2.80$47.82 64.3%10Short Interest ↑0.93%ALPNAlpine Immune Sciences$64.94+0.2%2 of 5 stars2.27$50.33 -22.5%11Short Interest ↓Positive News0.92%MDGLMadrigal Pharmaceuticals$205.25-0.8%5 of 5 stars2.73$345.09 68.1%11Earnings ReportAnalyst ForecastAnalyst Revision0.91%NUVLNuvalent$65.48-3.0%3 of 5 stars2.90$90.78 38.6%10Earnings ReportInsider SellingNews Coverage0.90%TMDXTransMedics Group$129.98+0.9%3 of 5 stars2.88$119.00 -8.4%8Insider SellingShort Interest ↓0.90%IMVTImmunovant$29.39-1.0%3 of 5 stars3.00$48.00 63.3%17Short Interest ↑0.82%INSMInsmed$25.97-1.6%4 of 5 stars3.00$45.08 73.6%12Earnings ReportAnalyst ForecastOptions VolumeNews Coverage0.79%CRNXCrinetics Pharmaceuticals$48.00-2.9%4 of 5 stars2.92$57.58 20.0%12Earnings ReportAnalyst ForecastInsider SellingShort Interest ↓News Coverage0.77%RAREUltragenyx Pharmaceutical$40.90-0.8%4 of 5 stars2.92$87.85 114.8%120.77%IOVAIovance Biotherapeutics$10.97-18.4%5 of 5 stars3.00$24.64 124.7%10Earnings ReportAnalyst ForecastNews CoverageGap DownHigh Trading Volume0.76%AXSMAxsome Therapeutics$72.50-1.6%5 of 5 stars2.92$121.92 68.2%13Analyst ForecastAnalyst RevisionNews Coverage0.74%IRTCiRhythm Technologies$99.01-0.9%1 of 5 stars3.00$134.00 35.3%70.72%JANXJanux Therapeutics$48.92-5.8%3 of 5 stars3.00$64.83 32.5%7Upcoming EarningsAnalyst ForecastAnalyst RevisionPositive NewsGap Down0.70%BHVNBiohaven$35.69-13.7%3 of 5 stars3.00$52.13 46.0%8Short Interest ↑News CoverageGap DownHigh Trading Volume0.69%SWTXSpringWorks Therapeutics$40.89-4.8%2 of 5 stars3.00$68.83 68.3%6Analyst Revision0.69%PRCTPROCEPT BioRobotics$62.65-0.6%1 of 5 stars3.00$61.20 -2.3%70.67%IDYAIDEAYA Biosciences$41.17+1.3%3 of 5 stars3.00$47.50 15.4%12Earnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionNews Coverage0.67%FOLDAmicus Therapeutics$9.23-2.6%5 of 5 stars3.00$20.00 116.7%6Earnings ReportAnalyst ForecastShort Interest ↓News Coverage0.65%ARWRArrowhead Pharmaceuticals$22.08-10.7%4 of 5 stars2.64$50.80 130.1%11Earnings ReportAnalyst ForecastShort Interest ↑News CoverageHigh Trading Volume0.64%AZTAAzenta$51.60-1.7%2 of 5 stars2.33$68.40 32.6%6Earnings ReportAnalyst ForecastNews Coverage0.62%ENOVEnovis$51.09+0.1%3 of 5 stars3.00$75.43 47.6%8Short Interest ↑0.62%SMMTSummit Therapeutics$4.65-2.7%1 of 5 stars3.00$7.50 61.3%2Analyst Forecast0.61%ACLXArcellx$49.74-5.7%3 of 5 stars3.00$78.20 57.2%12Earnings ReportUpcoming EarningsAnalyst ForecastNews Coverage0.60%TXG10x Genomics$25.99-1.5%5 of 5 stars2.58$48.50 86.6%120.58%CLDXCelldex Therapeutics$39.92-2.8%1 of 5 stars2.80$66.00 65.3%5Analyst ForecastAnalyst RevisionNews Coverage0.57%PTCTPTC Therapeutics$32.25+3.9%2 of 5 stars1.92$33.67 4.4%13Positive News0.57%CGONCG Oncology$28.50-5.1%1 of 5 stars2.75$61.75 116.7%4Gap Up0.56%TGTXTG Therapeutics$16.62-1.8%4 of 5 stars2.83$29.83 79.5%6Negative NewsGap Up0.54%RYTMRhythm Pharmaceuticals$39.14+1.7%3 of 5 stars2.83$54.33 38.8%6Earnings ReportAnalyst Forecast This page (NASDAQ:BTEC) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeHow Biden has already won 2024Porter & CompanyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Principal Healthcare Innovators ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
